Y mAbs Therapeutics (YMAB) — Free Cash Flow Generation Index
Latest as of June 2025:
1.00x
Y mAbs Therapeutics (YMAB) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of $1.65 Million represents 1% of operating cash flow ($1.65 Million). Check Y mAbs Therapeutics tangible equity quality to evaluate the tangible quality of the company's equity base.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
$1.65 Million
USD
Operating Cash Flow
$1.65 Million
USD
Capital Expenditures
$0.00
USD
Annual Free Cash Flow Generation for Y mAbs Therapeutics (None–None)
Year-by-year Free Cash Flow Generation Index for Y mAbs Therapeutics. Check total reinvestment intensity of Y mAbs Therapeutics to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).